Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane and cell wall of cariogenic oral bacteria, most notably Streptococcus mutans, represent the essential structural boundaries that protect the organism from the harsh, fluctuating environment of the human mouth. The cell wall is characterized by a thick layer of peptidoglycan interspersed with teichoic acids, which provides the rigidity necessary to withstand high osmotic pressure and serves as an anchor for surface proteins involved in adhesion to dental enamel (PubMed, 2021). Beneath the cell wall, the cytoplasmic membrane acts as a selective barrier and a site for critical metabolic processes, including ATP synthesis and nutrient transport. These structures are vital for the initiation and progression of dental caries, as they enable the bacteria to form resilient biofilms and survive the acidic byproducts of carbohydrate fermentation. Therapeutic intervention often involves the use of antiseptic rinses or antibiotics that compromise these barriers; for example, chlorhexidine binds to the negatively charged bacterial surface to disrupt membrane permeability, while penicillin-type drugs inhibit the enzymes responsible for cell wall assembly (NIH, 2022). Consequently, these components are fundamental targets in both preventive dentistry and the treatment of active oral infections.
Antimicrobial agents target these structures through several mechanisms: beta-lactams and glycopeptides inhibit the synthesis and cross-linking of the peptidoglycan layer in the cell wall, leading to osmotic lysis; biguanides and quaternary ammonium compounds disrupt the integrity of the cytoplasmic membrane, causing leakage of essential ions and molecules (PubMed, 2020; StatPearls, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and cell wall of cariogenic oral bacteria.